Skip Main Navigation
Page Content

Save This Event

Event Saved

ABC2 Research Lunch & Learn: First-Ever Adaptive Clinical Trial for GBM

ABC2

Tuesday, October 24, 2017 from 11:30 AM to 1:30 PM (EDT)

ABC2 Research Lunch & Learn: First-Ever Adaptive...

Ticket Information

Type End Quantity
In Person Oct 17, 2017 Free  

Who's Going

Loading your connections...

Share ABC2 Research Lunch & Learn: First-Ever Adaptive Clinical Trial for GBM

Event Details

 Brain Cancer Research Lunch & Learn 

11:30 am – 11:50 am – “Next Gen Clinical Trials and Personalized Medicine”

Speaker:  Max Wallace, CEO, ABC2 

11:50am - 12:30pm – Lunch  

12:30pm – 1:30pm – “INSIGhT Adaptive Clinical Trial for GBM”  (For those unable to attend in person, a live webcast of the discussion is scheduled to begin at 12:30 pm EST on Facebook Live)

INSIGhT is the first-ever adaptive clinical trial in brain cancer. It matches targeted therapies with the patients most likely to benefit from them.

Dana Farber is leading a 10-institution consortium (Massachusetts General Hospital, The University of Alabama at Birmingham, Mayo Clinic, Columbia, Cleveland Clinic, MD Anderson, University of Pittsburgh, Utah/Huntsman, and University of Virginia) that will test multiple drugs in newly diagnosed patients in a rapidly adaptive environment. 

As part of this, ABC² has joined with three pharmaceutical companies (Eli Lilly, Celgene and Puma Biotechnology) to fund the trial and ABC²'s Allele system does the front-end molecular analysis placing patients into the treatment arm most suitable for their individual tumor.  Five institutions in the consortium have now begun recruiting patients and the others are soon to follow. 

Speakers:  Dr. Brian Alexander, INSIGhT Principal Investigator, Dana-Farber Cancer Institute and David Sandak, Senior Vice President, Strategy and Research, ABC2

Moderator: Max Wallace, CEO, ABC2 

 

RSVP by October 13th, please contact us with any dietary restrictions for lunch

 

info@abc2.org | 202.419.3140 

 

2017 Science Salon Series Sponsored by Genentech 


 

FAQs 

What are my transportation/parking options for getting to and from the event?

Metro: Farragut North is the closest metro station to the ABC2 Office
Parking: There are numerous parking garages near the office and some metered street parking available 

How can I contact the organizer with any questions?

info@abc2.org | 202.419.3140  

Is it ok if the name on my ticket or registration doesn't match the person who attends?

Please contact us if you need to change the name on your ticket.

Will lunch be served?

Yes, we will be providing lunch for all attendees. Please contact us if you have any dietary restrictions.

Have questions about ABC2 Research Lunch & Learn: First-Ever Adaptive Clinical Trial for GBM? Contact ABC2

Save This Event

Event Saved

When & Where


The Case Foundation
1717 Rhode Island Avenue Northwest
Suite 700
Washington, DC 20036

Tuesday, October 24, 2017 from 11:30 AM to 1:30 PM (EDT)


  Add to my calendar
ABC2 Research Lunch & Learn: First-Ever Adaptive Clinical Trial for GBM
Things to do in Washington, DC Seminar Science & Tech

Interested in hosting your own event?

Join millions of people on Eventbrite.

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.